Alzheimer's Society For Researchers

Announcing our new strategic funding call: Accelerating Translation in Non-Alzheimer's dementia

This exciting new research initiative aims to unlock progress towards late-stage clinical studies to advance treatments in Lewy body, frontotemporal and vascular dementia.

While we know promising drug candidates exist for non-Alzheimer’s dementias, we also know without a significant amount of clinical evidence they can’t move to later stages of clinical trials.

That’s why we’re launching a new strategic funding call to give research teams the support they need to build the infrastructure necessary to increase the number of clinical trials in non-Alzheimer’s dementia.

We will be accepting applications for up to £2million to support a research programme for up to 5 years.

The call will open for outline applications on 8 June 2026: alzheimers.org.uk/what-we-do/res…

Sign up for our applicant webinar for more information:
alzheimers.zoom.us/webinar/regist…

We were delighted to be part of the conference organised by the Alzheimer’s Society Vascular and Immune Contributors to Dementia (VIDA) Doctoral Training Centre (DTC) at the University of Manchester last week.

A huge thank you to the VIDA DTC directors Stuart Allen, Anna Williams, Fatemeh Geranmayeh and Atticus Hainsworth and @GJBrainResearch for bringing the group together to hear all the latest from the VIDA team.

It was a pleasure to meet the first two cohorts of students and their supervisors during this unique collaborative opportunity which brought together basic and clinical science expertise from the University of Manchester, University of Edinburgh, St George’s University of London and Imperial College London.

It was inspiring to hear the incredible work being done to understand how blood vessel and immune system changes contribute to the underlying cause of dementia, with the aim of allowing earlier diagnosis and developing new treatments for those who need them.

Dementia is the biggest health and social care issue of our time and we need the brightest minds to take on this challenge.

These researchers will be the next generation of leaders in the field and will be critical to ending the devastation caused by dementia.

Our annual grant round is open for outline applications: alzheimers.org.uk/what-we-do/res…

It will take a society to beat dementia so we have a wide range of funding schemes available to support researchers, clinicians and health and social care professionals, from the beginning of their careers through to supporting their transition to academic independence.

Our Postdoctoral Fellow Dr Sasha Philbert is investigating biomarkers to distinguish between Alzheimer's disease and vascular dementia, which can look similar in their early stages.

He spoke with @ukfuturehealth about the search for biomarkers and how #OurFutureHealth can help advance dementia research: ourfuturehealth.org.uk/news/this-reso…

Congratulations to the winners of the @milbotix SmartSocks®DISCOVERY Pioneers competition! milbotix.com/smartsocks_dis…

Supported through our Accelerator programme, SmartSocks® collects physical and physiological data and can be used to investigate neurocognitive, movement and sleep disorders.